OUR BUSINESS MODEL

How it is used

CBD has been praised for a wide variety of health issues, and apart from ongoing cancer-studies, some of the strongest scientific evidence is for its effectiveness in treating some of the cruellest childhood epilepsy syndromes, such as Dravet Syndrome and Lennox-Gastaut Syndrome, which typically don’t respond to antiseizure medications. In numerous international studies, CBD was able to reduce the number of seizures, and in some cases, it was able to stop them completely. In other studies, aggressive Parkinson’s tremors have been reduced to almost negligible symptoms. Videos of the effects of CBD on children and their seizures, and Parkinson sufferers are readily available on the Internet for viewing, and they make a deep and lasting impression.

One area of great interest and frantic research is Oncology; it is thought that Cannabinoids may act as anti-tumour agents and be of great benefit in the treatment of certain types of cancer. Most estimates put the global oncology drugs market at $177 billion by 2025. Vivir is committed to initiating its own research and development in this field, but at present, it believes the oncology issue is in need of far more research, development and independent evaluation before CBD can be touted as any type of cure for cancer (although at present many proponents are stating it is certainly a help in the treatment of some cancers and their treatment regimen side-effects).

One of the more encouraging articles is from the Journal of the Molecular Cancer Therapeutics published by the California Pacific Medical Centre in which the researchers discovered that Cannabis has the ability to turn off the “Id-1 Gene” and therefore stop cancer in its tracks; the researchers treated breast cancer cells in their laboratory and treated them with CBD, they found that had “decreased Id-1 expressions and were less active/aggressive spreaders. The American Association for Cancer Research has also found that Cannabis actually works to slow down tumour growth in brain, breast and lungs considerably. We must not forget however, that “slowing down” or “less aggressive” in not a cure…. Yet?

The following table shows examples of a few of the medical applications that can be treated with Cannabis, and is certainly not an all-encompassing list; recently, economists are forecasting a $30.3 billion market by 2024 in dermatology alone.

CBD is also commonly used to address pain issues, anxiety, and for patients who suffer through the misery of insomnia, studies suggest that CBD may help with both falling asleep and staying asleep.

CBD is also commonly used to address pain issues, anxiety, and for patients who suffer through the misery of insomnia, studies suggest that CBD may help with both falling asleep and staying asleep.

CBD may offer an option for treating different types of chronic pain. A study from the European Journal of Pain showed that CBD applied on the skin could help lower pain and inflammation due to arthritis. Another study demonstrated the mechanism by which CBD inhibits inflammatory and neuropathic pain, two of the most difficult types of chronic pain to treat. More research and development is required in this area to substantiate the claims of CBD proponents about pain control. There is little doubt in our minds that the demand for the product is going to far outstrip supply.

Pain $85.4 B. 2025
Sleep Disorder $101.9 B. 2023
Arthritis $30.7 B. 2025
Epilepsy $17.3 B. 2027
Hyper tension $33.1 B. 2024
Glaucoma $7.6 B. 2026
Anxiety Disorder $7.5 B. 2023
Depression $14.7 B. 2025
ADHD $24.9 B. 2025
Autism $7.85 B. 2026
Addiction $7 B. 2025
PTSD $10.7 B. 2026
Pain $85.4 B. 2025
Sleep Disorder $101.9 B. 2023
Arthritis $30.7 B. 2025
Epilepsy $17.3 B. 2027
Hyper tension $33.1 B. 2024
Glaucoma $7.6 B. 2026
Anxiety Disorder $7.5 B. 2023
Depression $14.7 B. 2025
ADHD $24.9 B. 2025
Autism $7.85 B. 2026
Addiction $7 B. 2025
PTSD $10.7 B. 2026
Invest Now